| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-1 |
| Equity
Latest Equity |
22.09 |
| Face Value
Latest Face Value |
5 |
| Reserves
Total Reserve |
468.68 |
| Dividend
Full Year Dividend % |
0 |
| Sales Turnover
Full Year Net Sales |
381 |
| Net Profit
Full Year Net Profit |
14.26 |
| Full Year CPS
Full Year Cash Per Share |
7 |
| Earning Per Share
Full Year Earning Per Share |
3.2 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Mar 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
197.93 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
111.1 |
| Networth
Full Year Return on Networth |
17.18 |
| Price/Book Value
Price to Book value |
4.842484 |
| Yearly PE ratio
Full Year Price to Earning per share |
166.7 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
76.4 |
| Bse value
BSE Value in lakhs |
45.88 |
| Nse value
NSE Value in lakhs |
343.41 |
| High
52 week high |
705 |
| Low
52 week low |
400 |
| Price
NSE Current market price |
536 |
| CPM
Current market price |
538 |
| Market cap
BSE / NSE Market Cap |
2377.06 |
| Net profit
Latest Quarter Net Profit |
13.16 |
| Net profit variance
Latest Quarter Net Profit variance |
0 |
| Result year
Trailing latest month |
Mar 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
0 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
0 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
0 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
28.78 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
7.55 |
| TTM NP
Trailing Twelve 12 month Net Profit |
0 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
-1.16 |
| TTM EPS
Trailing Twelve 12 month EPS |
3.23 |
| TTM PE
Trailing Twelve 12 month PE |
166.58 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
0 |
| Equity
Latest Equity |
22.09 |
| LTP
Latest Price (BSE/NSE) |
538 |
| Gross block
Latest Gross Block |
79.5 |
| Loans
Total loans |
6.6 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
10.2 |
| Year GPM
Full Year Gross Profit Margin |
7.6 |
| Quarter OPM
Latest quater Operation Profit Margin |
13.2 |
| Dec 2025 | Mar 2026 | |
|---|---|---|
| + Sales | 96 | 198 |
| Gross Sales | 96 | 198 |
| + Expenses | 100 | 172 |
| Material Cost % | 58% | 53% |
| Raw Material Cost | 59 | 114 |
| Change in Inventory | -3 | -10 |
| Manufacturing Cost % | 29% | 18% |
| Employee Cost % | 11% | 6% |
| Other Cost % | 5% | 10% |
| Raw Materials % | 61% | 58% |
| Stock Adjustments % | 3% | 5% |
| Other Manufacturing Expenses % | 29% | 18% |
| Operating Profit | -4 | 26 |
| OPM % | -4% | 13% |
| + Other Income | 3 | 3 |
| Miscellaneous Income | 3 | 3 |
| Interest | 5 | 8 |
| Depreciation | 6 | 8 |
| Profit before tax | -12 | 12 |
| + Tax % | 43% | -6% |
| Current Tax | 1 | 1 |
| Deferred Tax | -6 | -2 |
| + Net Profit | -7 | 13 |
| Net Profit After Minority Interest | -7 | 13 |
| EPS in Rs | -2.22 | 4.02 |
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| + Sales | 97 | 154 | 163 |
| Sales Growth % | 59% | 6% | |
| + Expenses | 92 | 123 | 129 |
| Material Cost % | 60% | 62% | 58% |
| Raw Material Cost | 65 | 95 | 97 |
| Change in Inventory | -7 | 0 | -3 |
| Manufacturing Cost % | 3% | 3% | 3% |
| Employee Cost % | 9% | 8% | 8% |
| Other Cost % | 23% | 7% | 10% |
| Raw Materials % | 67% | 62% | 59% |
| Stock Adjustments % | 7% | 0% | 2% |
| Power & Fuel % | 2% | 2% | 1% |
| Other Manufacturing Expenses % | 2% | 1% | 2% |
| Selling & Administration % | 7% | 6% | 6% |
| Miscellaneous Expenses % | 2% | 1% | 1% |
| Operating Profit | 5 | 31 | 34 |
| OPM % | 5% | 20% | 21% |
| Other Income | 0 | 1 | 1 |
| Interest | 6 | 11 | 12 |
| Depreciation | 6 | 9 | 8 |
| Profit before tax | |||
| + Tax % | |||
| Current Tax | 3 | 4 | 5 |
| Deferred Tax | 0 | 0 | 0 |
| + Net Profit | |||
| Net Profit After Minority Interest | 4 | 8 | 14 |
| EPS in Rs | 6.12 | 6.35 | 5.43 |
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 7 | 13 | 13 |
| Reserves | 24 | 61 | 80 |
| + Borrowings | 69 | 119 | 94 |
| Secured Borrowings | 68 | 114 | 87 |
| Unsecured Borrowings | 1 | 5 | 7 |
| + Other Liabilities | 34 | 75 | 85 |
| Current Liabilities | 34 | 73 | 82 |
| Provisions | 7 | 12 | 14 |
| Minority Interest | 0 | 2 | 2 |
| Other liability items | 0 | 0 | 1 |
| Total Liabilities | 134 | 268 | 272 |
| + Fixed Assets | 44 | 70 | 53 |
| Gross Block | 55 | 99 | 80 |
| Accumulated Depreciation | 11 | 29 | 26 |
| CWIP | 2 | 0 | 1 |
| Investments | 0 | 0 | 0 |
| + Other Assets | 88 | 198 | 219 |
| Inventories | 13 | 37 | 51 |
| Trade receivables | 61 | 127 | 127 |
| Cash Equivalents | 0 | 4 | 2 |
| Loans n Advances | 7 | 19 | 21 |
| Other asset items | 6 | 10 | 18 |
| Total Assets | 134 | 268 | 272 |
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| + Cash from Operating Activity | -13 | -30 | 33 |
| Profit from Operations | 19 | 33 | 40 |
| Working Capital Changes | -29 | -63 | -7 |
| Profit Before Tax & Extraordinary Items | 7 | 13 | 20 |
| Depreciation | 6 | 9 | 8 |
| Interest (Net) | 5 | 11 | 12 |
| Provisions & Write-offs (Net) | 0 | 1 | 0 |
| Profit / Loss in Forex | 1 | 0 | 1 |
| Receivables | -30 | -66 | 1 |
| Inventories | -10 | -24 | -14 |
| Trade Payables | 6 | 31 | 5 |
| Loans & Advances | 1 | -4 | 3 |
| Direct Taxes Paid | -3 | 0 | -1 |
| + Cash from Investing Activity | -19 | -46 | 0 |
| Purchase of Fixed Assets | -17 | -44 | 0 |
| Sale of Fixed Assets | 0 | 0 | 9 |
| Purchase of Investments | 0 | -1 | -1 |
| Capital WIP | 0 | 2 | -1 |
| Interest Received | 0 | 0 | 0 |
| Others | -2 | -3 | -7 |
| + Cash from Financing Activity | 24 | 79 | -36 |
| Proceeds from Issue of Shares | 3 | 39 | 1 |
| Proceeds from Other Long-Term Borrowings | 21 | 13 | 0 |
| Proceeds from Short-Term Borrowings | 12 | 37 | 0 |
| Repayment of Long-Term Borrowings | -7 | 0 | -25 |
| Interest Paid | -5 | -11 | -12 |
| Net Cash Flow | -8 | 2 | -2 |